Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 11 studies | 28% ± 11% | |
B cell | 9 studies | 22% ± 5% | |
naive B cell | 7 studies | 19% ± 4% | |
adipocyte | 7 studies | 29% ± 12% | |
endothelial cell | 6 studies | 24% ± 6% | |
microglial cell | 6 studies | 27% ± 8% | |
oligodendrocyte | 6 studies | 23% ± 5% | |
epithelial cell | 4 studies | 27% ± 4% | |
GABAergic neuron | 4 studies | 39% ± 14% | |
astrocyte | 4 studies | 28% ± 6% | |
glutamatergic neuron | 4 studies | 46% ± 17% | |
oligodendrocyte precursor cell | 4 studies | 28% ± 8% | |
classical monocyte | 3 studies | 19% ± 3% | |
memory B cell | 3 studies | 17% ± 0% | |
myeloid cell | 3 studies | 22% ± 7% | |
precursor B cell | 3 studies | 18% ± 2% | |
ciliated cell | 3 studies | 23% ± 2% | |
dendritic cell | 3 studies | 22% ± 4% | |
monocyte | 3 studies | 24% ± 5% | |
interneuron | 3 studies | 40% ± 20% | |
neuron | 3 studies | 25% ± 8% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 6 studies | 34% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 1738.85 | 577 / 578 | 100% | 8.92 | 1152 / 1155 |
esophagus | 100% | 1145.13 | 1445 / 1445 | 99% | 8.19 | 182 / 183 |
intestine | 100% | 1583.16 | 966 / 966 | 99% | 9.32 | 521 / 527 |
stomach | 100% | 1257.94 | 358 / 359 | 99% | 9.00 | 283 / 286 |
breast | 100% | 1887.71 | 459 / 459 | 99% | 12.73 | 1103 / 1118 |
pancreas | 100% | 941.38 | 327 / 328 | 98% | 8.61 | 175 / 178 |
bladder | 100% | 1382.14 | 21 / 21 | 98% | 8.77 | 492 / 504 |
thymus | 100% | 1523.94 | 653 / 653 | 97% | 9.44 | 587 / 605 |
kidney | 100% | 1078.19 | 89 / 89 | 97% | 9.10 | 873 / 901 |
ovary | 100% | 1624.83 | 180 / 180 | 97% | 6.50 | 416 / 430 |
uterus | 100% | 1348.50 | 170 / 170 | 95% | 7.96 | 438 / 459 |
prostate | 100% | 1209.70 | 245 / 245 | 95% | 7.24 | 477 / 502 |
brain | 97% | 943.93 | 2558 / 2642 | 98% | 8.52 | 692 / 705 |
skin | 100% | 1735.94 | 1809 / 1809 | 94% | 7.81 | 446 / 472 |
liver | 100% | 1150.39 | 226 / 226 | 88% | 5.42 | 359 / 406 |
adrenal gland | 100% | 1664.14 | 258 / 258 | 76% | 3.61 | 175 / 230 |
lymph node | 0% | 0 | 0 / 0 | 100% | 11.51 | 29 / 29 |
spleen | 100% | 3984.28 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.48 | 1 / 1 |
adipose | 100% | 1912.61 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 992.39 | 1331 / 1335 | 0% | 0 | 0 / 0 |
muscle | 98% | 543.18 | 787 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 8.32 | 43 / 45 |
heart | 93% | 571.21 | 799 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 90% | 1846.65 | 833 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 74% | 4.53 | 59 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006629 | Biological process | lipid metabolic process |
GO_0006657 | Biological process | CDP-choline pathway |
GO_0006646 | Biological process | phosphatidylethanolamine biosynthetic process |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0031965 | Cellular component | nuclear membrane |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0004142 | Molecular function | diacylglycerol cholinephosphotransferase activity |
GO_0047359 | Molecular function | 1-alkenyl-2-acylglycerol choline phosphotransferase activity |
GO_0004307 | Molecular function | ethanolaminephosphotransferase activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | CEPT1 |
Protein name | Choline/ethanolaminephosphotransferase 1 (hCEPT1) (EC 2.7.8.1) (EC 2.7.8.2) (1-alkenyl-2-acylglycerol choline phosphotransferase) (EC 2.7.8.22) Choline/ethanolaminephosphotransferase 1 (EC 2.7.8.1) (EC 2.7.8.2) (EC 2.7.8.22) (1-alkenyl-2-acylglycerol choline phosphotransferase) |
Synonyms | hCG_39981 PRO1101 |
Description | FUNCTION: Catalyzes both phosphatidylcholine and phosphatidylethanolamine biosynthesis from CDP-choline and CDP-ethanolamine, respectively. Involved in protein-dependent process of phospholipid transport to distribute phosphatidyl choline to the lumenal surface. Has a higher cholinephosphotransferase activity than ethanolaminephosphotransferase activity. . FUNCTION: Catalyzes both phosphatidylcholine and phosphatidylethanolamine biosynthesis from CDP-choline and CDP-ethanolamine, respectively. Involved in protein-dependent process of phospholipid transport to distribute phosphatidyl choline to the lumenal surface. Has a higher cholinephosphotransferase activity than ethanolaminephosphotransferase activity. . FUNCTION: Catalyzes both phosphatidylcholine and phosphatidylethanolamine biosynthesis from CDP-choline and CDP-ethanolamine, respectively. Involved in protein-dependent process of phospholipid transport to distribute phosphatidyl choline to the lumenal surface. Has a higher cholinephosphotransferase activity than ethanolaminephosphotransferase activity. . FUNCTION: Catalyzes both phosphatidylcholine and phosphatidylethanolamine biosynthesis from CDP-choline and CDP-ethanolamine, respectively. Involved in protein-dependent process of phospholipid transport to distribute phosphatidyl choline to the lumenal surface. Has a higher cholinephosphotransferase activity than ethanolaminephosphotransferase activity. . |
Accessions | ENST00000700750.1 Q9Y6K0 ENST00000700751.1 ENST00000700752.1 ENST00000357172.9 A0A8V8TQL1 A0A8V8TRF3 ENST00000545121.5 A0A8V8TQ23 |